These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11027850)

  • 21. Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population.
    Zhang ZJ; Burgunder JM; An XK; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Mao XY; Peng R
    Neurosci Lett; 2008 Sep; 442(3):200-2. PubMed ID: 18638528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UCH-L1 S18Y variant and risk of Parkinson's disease in Asian populations: an updated meta-analysis.
    Zhu R; Zhu Y; Liu X; He Z
    Neurodegener Dis; 2014; 14(4):194-203. PubMed ID: 25471998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells.
    Kyratzi E; Pavlaki M; Stefanis L
    Hum Mol Genet; 2008 Jul; 17(14):2160-71. PubMed ID: 18411255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.
    Xilouri M; Kyratzi E; Pitychoutis PM; Papadopoulou-Daifoti Z; Perier C; Vila M; Maniati M; Ulusoy A; Kirik D; Park DS; Wada K; Stefanis L
    Hum Mol Genet; 2012 Feb; 21(4):874-89. PubMed ID: 22076440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.
    Liu Y; Chen YY; Liu H; Yao CJ; Zhu XX; Chen DJ; Yang J; Lu YJ; Cao JY
    Neurol Sci; 2015 Feb; 36(2):179-88. PubMed ID: 25370916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD.
    Savettieri G; De Marco EV; Civitelli D; Salemi G; Nicoletti G; Annesi G; Cirò Candiano IC; Quattrone A
    Neurology; 2001 Aug; 57(3):560-1. PubMed ID: 11502942
    [No Abstract]   [Full Text] [Related]  

  • 27. Complex interactions in Parkinson's disease: a two-phased approach.
    Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
    Xu EH; Tang Y; Li D; Jia JP
    J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
    Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms.
    Momose Y; Murata M; Kobayashi K; Tachikawa M; Nakabayashi Y; Kanazawa I; Toda T
    Ann Neurol; 2002 Jan; 51(1):133-6. PubMed ID: 11782995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
    Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
    J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.
    Hutter CM; Samii A; Factor SA; Nutt JG; Higgins DS; Bird TD; Griffith A; Roberts JW; Leis BC; Montimurro JS; Kay DM; Edwards KL; Payami H; Zabetian CP
    Eur J Neurol; 2008 Feb; 15(2):134-9. PubMed ID: 18093156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1.
    Andersson FI; Werrell EF; McMorran L; Crone WJ; Das C; Hsu ST; Jackson SE
    J Mol Biol; 2011 Mar; 407(2):261-72. PubMed ID: 21251915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
    Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
    Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
    Lee YC; Hsu SD
    Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between UCHL1 S18Y gene polymorphism and Parkinson's disease in the Asian population: a meta-analysis.
    Sun S; Zhao Y; Jin G; Kang H
    Neurol Sci; 2014 Dec; 35(12):1867-76. PubMed ID: 25354657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UCHL1 is a Parkinson's disease susceptibility gene.
    Maraganore DM; Lesnick TG; Elbaz A; Chartier-Harlin MC; Gasser T; Krüger R; Hattori N; Mellick GD; Quattrone A; Satoh J; Toda T; Wang J; Ioannidis JP; de Andrade M; Rocca WA;
    Ann Neurol; 2004 Apr; 55(4):512-21. PubMed ID: 15048890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.
    Miyake Y; Tanaka K; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    BMC Neurol; 2012 Jul; 12():62. PubMed ID: 22839974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease.
    Zhang J; Hattori N; Leroy E; Morris HR; Kubo S; Kobayashi T; Wood NW; Polymeropoulos MH; Mizuno Y
    Parkinsonism Relat Disord; 2000 Oct; 6(4):195-197. PubMed ID: 10900392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.
    Zetterberg M; Sjölander A; von Otter M; Palmér MS; Landgren S; Minthon L; Wallin A; Andreasen N; Blennow K; Zetterberg H
    Mol Neurodegener; 2010 Mar; 5():11. PubMed ID: 20302621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.